Diurnal Enuresis (Daytime Wetting)

10/01/2006 - "Improved efficacy of extended release oxybutynin in children with persistent daytime urinary incontinence converted from regular oxybutynin."
12/01/2006 - "Frequency of wetting and response to oxybutynin in children with daytime urinary incontinence."
10/01/2006 - "A retrospective review of patients with daytime wetting who switched from Ditropan to Ditropan XL included patient age, sex, reason for the change in medication, uroflowmetry findings before and after the change, side effects, and duration and dosage of the medication. "
10/01/2006 - "To examine the response to conversion from regular oxybutynin (Ditropan) to an extended-release form (Ditropan XL) in children with persistent daytime urinary incontinence. "
05/01/2006 - "To examine the variables relative to the response of oxybutynin treatment in children with daytime urinary incontinence. "

01/01/2009 - "Finally in the third study the use of desmopressin in women complaining of daytime urinary incontinence is reported. "
05/01/2004 - "The results of this exploratory study suggest that desmopressin is an effective and safe treatment in women with daytime urinary incontinence, and allows them to choose when they need treatment, thus improving motivation, which may aid compliance with therapy."
05/01/2004 - "To investigate the efficacy of desmopressin nasal spray on daytime urinary incontinence in women. "
09/01/2005 - "Combination medication (desmopressin and anticholinergics) was administered for coexisting diurnal enuresis, which was present in 8 children. "
01/01/1997 - "Nocturnal enuresis and daytime wetting: a multicentric trial with oxybutynin and desmopressin."

02/01/1997 - "Anticholinergic drugs might have a role in diurnal enuresis, but their role in NE with daytime symptoms is not yet established. "
05/01/2007 - "The results of our study have indicated that anticholinergic therapy appears to be overused as a first-line treatment for children with daytime urinary incontinence in our clinic population. "
05/01/2007 - "To analyze the relationship between potential prognostic factors and early success after treatment of childhood daytime urinary incontinence without anticholinergic medication. "
08/01/2002 - "Most girls with daytime wetting will respond to conservative therapy using timed voiding, dietary changes, and anticholinergic medication. "
02/01/2020 - "Children with daytime urinary incontinence secondary to idiopathic overactive bladder (IOAB) commonly present to paediatric urologists following failure of standard urotherapy and/or 1st-line anticholinergics. "

02/01/2005 - "Should we switch over to tolterodine in every child with non-neurogenic daytime urinary incontinence in whom oxybutynin failed?"
02/01/2005 - "The results of this study in children with non-neurogenic daytime urinary incontinence have shown that tolterodine may increase the efficacy of pharmacotherapy, particularly in patients noncompliant to oxybutynin. "
02/01/2005 - "To assess the clinical efficacy of tolterodine prescribed to children with non-neurogenic daytime urinary incontinence secondary to overactive bladder who had previously failed to improve with oral oxybutynin treatment and its relation to the side-effect profile and compliance status. "

03/06/1991 - "Thus the findings show terodiline to be effective in the treatment of diurnal enuresis, an added advantage being the low incidence of side effects. "
03/06/1991 - "[Diurnal enuresis in childhood is effectively treated with terodiline]."
05/01/1988 - "Terodiline in the treatment of diurnal enuresis in children."
01/01/1984 - "Terodiline in children with diurnal enuresis."
03/06/1991 - "Efficacy and tolerance of the anticholinergic calcium antagonist, terodiline (Mictrol), were investigated in a placebo-controlled double-blind cross-over study of 42 children with diurnal enuresis. "

05/01/2004 - "To investigate the efficacy of desmopressin nasal spray on daytime urinary incontinence in women. "

12/01/2013 - "To determine whether the adrenoceptor agonist, ephedrine hydrochloride, is an effective treatment for resistant non-neurogenic daytime urinary incontinence in children. "

12/01/2013 - "Oral ephedrine hydrochloride is an effective treatment for carefully selected children with resistant non-neurogenic daytime urinary incontinence."
12/01/2013 - "From 2000 to 2010, eighteen children with resistant non-neurogenic daytime urinary incontinence were treated with oral ephedrine hydrochloride at our institution. "
12/01/2013 - "Ephedrine hydrochloride: novel use in the management of resistant non-neurogenic daytime urinary incontinence in children."
12/01/2013 - "To determine whether the adrenoceptor agonist, ephedrine hydrochloride, is an effective treatment for resistant non-neurogenic daytime urinary incontinence in children. "

09/01/1982 - "Twenty-seven children with diurnal enuresis were studied in a double-blind randomised controlled trial of imipramine. "
09/01/1982 - "Controlled trial of imipramine in diurnal enuresis."

01/01/1992 - "There is no evidence from properly controlled studies that tricyclic antidepressants or anticholinergic drugs are of value for the child with daytime wetting. "

06/01/2005 - "Fifteen boys ranging between 5 and 15 years old consulted our clinics for nocturnal and diurnal enuresis which had not been improved by medication and behavioral therapy. "
09/01/2000 - "We report the long-term efficacy of behavioral therapy for daytime wetting. "
09/01/2000 - "Long-term efficacy of simple behavioral therapy for daytime wetting in children."
01/01/2009 - "The principle aim of this thesis is to assess the role of antidiuresis in women complaining of daytime urinary incontinence and also to examine its role as a 'designer therapy' which women can choose to use as, or when, required. "
04/01/2006 - "They received BFB therapy during the last year for daytime urinary incontinence. "

01/01/2019 - "Biofeedback as single first-line treatment for non-neuropathic dysfunctional voiding children with diurnal enuresis."
01/01/2019 - "Biofeedback (BF) is a promising, non-invasive modality for treating children with DV and daytime wetting. "
09/01/2000 - "Behavioral therapy has proved benefit for children with daytime wetting but most studies have used biofeedback techniques and provide no long-term assessment of results. "
09/01/2000 - "Simple behavioral therapy without biofeedback techniques is an effective and durable first line therapy for children with daytime wetting."
12/01/2001 - "Biofeedback is a noninvasive treatment that has been documented to be helpful for children with daytime wetting and/or urinary tract infection secondary to voiding dysfunction. "

03/15/1995 - "Prompted voiding, a simple, noninvasive behavioral intervention, is effective in managing daytime urinary incontinence in one quarter to one third of incontinent nursing home residents. "
10/01/1993 - "To determine the incidence and remission rates of daytime urinary incontinence (UI) in a cohort of newly admitted nursing home (NH) residents. "

02/01/2005 - "The results of this study in children with non-neurogenic daytime urinary incontinence have shown that tolterodine may increase the efficacy of pharmacotherapy, particularly in patients noncompliant to oxybutynin. "

01/01/2022 - "To investigate if children with daytime urinary incontinence (DUI) and overactive bladder (OAB) refractory to standard urotherapy and medicinal treatment, would experience improvement in symptoms after add-on treatment with transcutaneous electrical nerve stimulation (TENS). "
09/01/2017 - "To evaluate the immediate effect on natural fill urodynamic parameters and bladder function during transcutaneous electrical nerve stimulation (TENS) in children with overactive bladder (OAB) and daytime urinary incontinence (DUI). "
10/01/2009 - "We studied the effect of transcutaneous electrical nerve stimulation in children with overactive bladder and treatment refractory daytime urinary incontinence. "
01/01/2022 - "Transcutaneous electrical nerve stimulation as add-on therapy in children receiving anticholinergics and/or mirabegron for refractory daytime urinary incontinence: A retrospective cohort study."